Stay updated on Benralizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.4.2 was added to the page. The government funding status notice and the prior revision notice for v3.4.1 were removed.SummaryDifference0.3%

- Check57 days agoChange DetectedA site-wide government funding status notice was added, stating that information may not be up to date and where to check for updates. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check64 days agoChange DetectedAdded a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and the site revision tag 'Revision: v3.4.0'. The wording for FEAR Act data changed to 'No FEAR Act Data' and the corresponding label from the previous version ('No FEAR Act data' and 'Revision: v3.3.4').SummaryDifference0.1%

- Check78 days agoChange DetectedMinor UI/metadata update: Revision label updated from v3.3.3 to v3.3.4 on the page. This change does not affect study data, eligibility criteria, or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.